Taylor is responsible for BII’s science scouting to identify research with translational commercial potential. She oversees these projects throughout their time in the program, and works through the due diligence process.

Originally from New Zealand, Taylor holds a PhD in Biomedical Engineering from Victoria University of Wellington. She is experienced in drug design, chemical synthesis, and biological testing, having worked in a biotech start up and as an academic post doc. Passionate about merging business and science, she has sat on investment committee boards as both a board member and chairperson.